Registry of Patients Treated With Systemic Mold-Active Triazoles

What is the purpose of this trial?

The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).


Participation Guidelines

Ages: 6 - 80 years

Gender: Both


Astellas Pharma US, Inc.

Dates: 10/11/2017 - 12/31/2020

Last Updated: 10/17/2017

Study HIC#: 2000020126REG

Get Involved

For more information about this study, contact:
Xiaojie Guo
+1 203-785-2365
xiaojie.guo@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigator

Maricar Malinis

Principal Investigator